NCT07057297

Brief Summary

This prospective, multicenter observational study aims to evaluate the incidence, timing, and characteristics of residual and recurrent (restenosis) carotid artery stenosis following carotid endarterectomy (CEA) with primary closure. Conducted across several neurosurgical centers in the Czech Republic, the study will include patients undergoing elective CEA who meet standard clinical indications. Participants will undergo preoperative CT angiography and follow-up imaging at 30 days and 1 year post-surgery. Residual stenosis is defined as ≥50% luminal narrowing detected within 30 days postoperatively, while restenosis is evaluated at later time points. The study will also assess clinical outcomes such as ischemic stroke, TIA, myocardial infarction, and mortality. The standardized surgical technique and harmonized diagnostic algorithm across all centers aim to provide robust data on the performance and durability of primary closure CEA.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
8mo left

Started Feb 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2025Jan 2027

Study Start

First participant enrolled

February 1, 2025

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

June 30, 2025

Completed
9 days until next milestone

First Posted

Study publicly available on registry

July 9, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2026

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Expected
Last Updated

July 9, 2025

Status Verified

June 1, 2025

Enrollment Period

11 months

First QC Date

June 30, 2025

Last Update Submit

June 30, 2025

Conditions

Keywords

Carotid ArteryAtherosclerosisEndarterectomyStroke

Outcome Measures

Primary Outcomes (1)

  • Restenosis ≥50% at 12 months

    Restenosis ≥50% at 12 months

    12 months

Secondary Outcomes (3)

  • Restenosis ≥50%

    30 days

  • iCMP/TIA/death/MI

    1 year

  • Change in modified Rankin Scale (mRS)

    1 year

Study Arms (1)

Patients after carotid endarterectomy

Included paitnets with sign informed consent after carotid endarterectomy

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who undergo carotid endarterectomy for carotid artery stenosis with primary suture.

You may not qualify if:

  • Age ≤18 or ≥90 years
  • Previous endarterectomy or stenting
  • Unsuitable vascular anatomy
  • High perioperative risk
  • Contralateral cranial nerve X or XII palsy
  • History of neck irradiation
  • Tandem carotid stenosis or intracranial vascular pathology (e.g., aneurysm or AVM)
  • Absence of signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Central Military Hospital Prague

Prague, 16200, Czechia

RECRUITING

MeSH Terms

Conditions

Carotid Artery DiseasesCarotid StenosisAtherosclerosisStroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesArterial Occlusive DiseasesArteriosclerosis

Central Study Contacts

norbert Svoboda, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
cpt. MD. Norbert Svoboda, PhD., FEBNS

Study Record Dates

First Submitted

June 30, 2025

First Posted

July 9, 2025

Study Start

February 1, 2025

Primary Completion

January 1, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

July 9, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Epidemiologic risk factors: age, sex, diabetes, hypertension, dyslipidemia, metabolic syndrome, renal insufficiency, smoking, physical activity, weight, comorbidities Laboratory markers: LDL, HDL, cholesterol, lipoprotein A, triglycerides, CKD-EPI, sedimentation rate, fibrinogen, INR (Quick test), APTT

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR, ANALYTIC CODE
Time Frame
2/2027 - 2/2028
Access Criteria
online

Locations